Helpap B
Institut für Pathologie, Hegau-Klinikum Singen, Akademisches Lehrkrankenhaus, Universität Freiburg.
Verh Dtsch Ges Pathol. 2002;86:57-66.
The WHO classification of urothelial carcinomas of the urinary bladder (1999) presents the papillary urothelial neoplasia of low malignant potential (PUNLMP) as a new entity in between the papillomas and the papillary urothelial carcinomas. This neoplasia shows a typical basal palisading, a low mitotic rate, and a low MIB-1-proliferation index. The PUNLMP is said to have an increased risk of development of recurrent papillary lesions with the possibility of malignant transformation. At present, there is an intensive discussion on this new entity. The participants of a meeting on the consensus classification on urothelial tumors held in Ancona in 2000 have meanwhile split in two discussion groups. One favors the new WHO classification with the papillary urothelial carcinomas G I, G II, and G III, but without PUNLMP, whereas the other group favors the consensus classification of 1998 with papillomas, papillary urothelial neoplasia of low malignant potential, and non invasive as well as invasive low-grade and high grade papillary urothelial carcinomas. Future long term prospective studies will show the significance of PUNLMP compared to well differentiated non invasive papillary urothelial urinary bladder carcinoma G I (G Ia). Otherwise, there is no significant difference in the classification of carcinomas and non epithelial lesions compared with the previous classification of 1973. The new WHO does however discriminate the minimally invasive papillary urothelial carcinomas in those with infiltration of the lamina propria above the muscularis mucosae (pT1a), the infiltration of the lamina muscularis mucosae (pT1b), and the extension beyond the muscularis mucosae (pT1c). The recurrence rate increases from stage pT1b. This substaging may be of therapeutical relevance.
世界卫生组织膀胱尿路上皮癌分类(1999年)将低恶性潜能乳头状尿路上皮肿瘤(PUNLMP)列为介于乳头状瘤和乳头状尿路上皮癌之间的一种新实体。该肿瘤表现出典型的基底栅栏状、低有丝分裂率和低MIB-1增殖指数。据说PUNLMP发生复发性乳头状病变并有可能恶变的风险增加。目前,关于这个新实体有激烈的讨论。2000年在安科纳举行的尿路上皮肿瘤共识分类会议的参与者同时分成了两个讨论组。一组支持新的世界卫生组织分类,即乳头状尿路上皮癌G I、G II和G III,但不包括PUNLMP,而另一组则支持1998年的共识分类,包括乳头状瘤、低恶性潜能乳头状尿路上皮肿瘤以及非浸润性和浸润性低级别和高级别乳头状尿路上皮癌。未来的长期前瞻性研究将显示PUNLMP与高分化非浸润性乳头状膀胱尿路上皮癌G I(G Ia)相比的意义。否则,与1973年以前的分类相比,癌和非上皮性病变的分类没有显著差异。然而,新的世界卫生组织确实区分了微浸润性乳头状尿路上皮癌,分为黏膜肌层上方固有层浸润(pT1a)、黏膜肌层浸润(pT1b)和超出黏膜肌层(pT1c)。复发率从pT1b期开始增加。这种亚分期可能具有治疗相关性。